BRAIN Initiative: ZEI Participates in the US BRAIN Initiative

JENA/Germany, WASHINGTON D.C./USA, 09.10.2014.

The National Institutes of Health (NIH) announced its first research grants through President Barack Obamas BRAIN Initiative, including three awards to the University of California, Berkeley, totaling nearly $7.5 million over three years. In addition, a $12 million public-private collaboration between ZEISS and UC Berkeley to support the Berkeley Brain Microscopy Innovation Center (BrainMIC) was made public.

The US Brain initiative is focused on advancing tool development in neuroscience including microscopy and advanced imaging technologies. Jim Sharp, President of the ZEISS business group Microscopy in North America, represented ZEISS at the White House BRAIN Initiative Conference on 30th September. New commitments and investments by the federal government, private sector companies, universities and non-profit organizations in response to the President's call to action were announced.

Thanks to the collaboration with ZEISS, the BrainMIC at UC Berkeley will be able to fast-track microscopy development for emerging neurotechnologies and will run an annual course to teach researchers how to use the new technologies. Part of the Helen Wills Neuroscience Institute, the program will generate innovative devices and analytic tools in engineering, computation, chemistry and molecular biology to enable transformative brain science from studies of human cognition to neural circuits in model organisms.

The White House BRAIN Initiative

Dr. Jochen Tham

Carl Zeiss Microscopy GmbH

Phone: +49 3641 64-3949

Fax:

jochen.tham@zeiss.com

About ZEISS

ZEISS is an international leader in the fields of optics and optoelectronics. The more than 24,000 employees of ZEISS generated revenue of about 4.2 billion euros in fiscal year 2012/13. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. ZEISS has been contributing to technological progress for more than 160 years. ZEISS develops and produces solutions for the semiconductor, automotive and mechanical engineering industries, biomedical research and medical technology, as well as eyeglass lenses, camera and cine lenses, binoculars and planetariums. ZEISS is present in over 40 countries around the globe with more than 40 production facilities, around 50 sales and service locations and over 20 research and development sites. Carl Zeiss AG is fully owned by the Carl-Zeiss-Stiftung (Carl Zeiss Foundation).

The Microscopy Business Group

The Microscopy business group is the worlds only one-stop manufacturer of light, X-ray and electron microscopes. Its extensive portfolio enables research and routine applications in the life and materials sciences. The Microscopy business group is headquartered in Jena. Additional production and development sites are located in Oberkochen, G ttingen and Munich, as well as in Cambridge in the UK, in Peabody, MA and Pleasanton, CA in the USA. The business group has around 3,000 employees. It generated revenue of 629 million euros in fiscal year 2012/13.

Number: 0126-2014-ENG MI

Number of Words: 258

Number of Characters: 2104

LINK:	http://applications.zeiss.com/C1256A770030BCE0/WebViewTopNewsAllE/C086...
	See more stories from zeiss

Most recent headlines